Diaceutics PLC (DXRX) — Cash Flow Quality Index
Diaceutics PLC (DXRX) has a Cash Flow Quality Index of -0.57x as of December 2024. Operating cash flow of GBX-501.00K is below net income of GBX881.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore DXRX cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Diaceutics PLC Cash Flow Quality Index (2016–2022)
Historical Cash Flow Quality Index for Diaceutics PLC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Diaceutics PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Diaceutics PLC (2016–2022)
Year-by-year earnings quality comparison for Diaceutics PLC. For live market cap and the full company financial profile, see Diaceutics PLC market cap and net worth.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 7.04x | GBX5.10 Million | GBX724.00K | ▲ +592.8% |
| 2021 | 1.02x | GBX570.00K | GBX561.00K | ▲ +5.6% |
| 2020 | 0.96x | GBX253.00K | GBX263.00K | ▲ +161.0% |
| 2019 | -1.58x | GBX-627.05K | GBX397.88K | ▼ -4.5% |
| 2018 | -1.51x | GBX-954.04K | GBX632.31K | ▼ -177.2% |
| 2017 | 1.95x | GBX1.53 Million | GBX784.86K | ▲ +127.7% |
| 2016 | 0.86x | GBX674.01K | GBX784.98K | — |